DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Santoro A, Rimassa L, Borbath I et al.
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.
Lancet Oncol 2013;
14: 55-63
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.